An evidence development process for newborn screening
Department of Pediatrics; New England Newborn Screening Program
*Evidence-Based Medicine; *Expert Testimony; Health Plan Implementation; Humans; Infant, Newborn; *Neonatal Screening; Patient Advocacy; Rare Diseases; United States
Genetics and Genomics | Medical Genetics | Pediatrics
This article describes the background, development, and initial implementation of new procedures for the systematic review of key issues in newborn screening. Building on the work of other systematic review efforts, the Evidence Review Group described here has aimed to develop consistent and transparent strategies for evidence review. This process has helped to strengthen a complex analysis and decision system by providing balanced evidence, taking into account available high-quality data, expert opinion, and other levels of evidence, in a transparent manner. The methods developed and the identification of areas of missing data may also help investigators begin to standardize the clinical and laboratory data they collect pertaining to the newborn screening and diagnosis of rare disorders and their outcomes and focus future research efforts in the most needed areas.
DOI of Published Version
Genet Med. 2010 Mar;12(3):131-4. Link to article on publisher's site
Genetics in medicine : official journal of the American College of Medical Genetics
Perrin, James M.; Knapp, Alixandra A.; Browning, Marsha F.; Comeau, Anne Marie; Green, Nancy S.; Lipstein, Ellen A.; Metterville, Danielle R.; Prosser, Lisa A.; Queally, Denise; and Kemper, Alex R., "An evidence development process for newborn screening" (2010). Genetics. 26.